Illicit drug markets operate through a complex, global chain—from production and trafficking to consumption and the profits that fuel organised crime. At every stage, these activities compromise the health and security of countries...
This groundbreaking book breaks down the latest research to reveal how trauma impacts our bodies on a cellular level and offers an empowering path to whole-body healing.
Today, we know more about mental health than ever before, but...
The European Union and Central Asian countries have joined forces through the EU–Central Asia Action Plan on Drugs 2014–2020, building on earlier cooperation dating back to 2002. This plan recognises the shared challenges posed by drug...
The International Narcotics Control Board’s 2015 report on precursors highlights global efforts to stop chemicals being diverted into the illicit manufacture of drugs. It points to successes achieved through international cooperation...
In 2015, the UNODC-WCO Container Control Programme (CCP) expanded its reach with new Port Control Units (PCUs) across Asia and Europe, including in Bangladesh, Bosnia and Herzegovina, Georgia, Jordan, Nepal, Thailand and Viet Nam, as well...
Building the Future Together: Joanna Travis-Roberts on 10 Years of ISSUP
A special three-part series celebrating 10 years of the International Society of Substance Use Professionals (ISSUP).
In this first episode, host Associate...
Background
Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid...
This EMCDDA paper introduces the European Union’s approach to drug supply reduction, explaining how policies, structures, and actions are designed to disrupt drug markets and limit the availability of illicit substances. It highlights the...
